Phase Forward Hosts Third Annual International Users Conference

Business Wire, Oct 12, 2004

Phase Forward (NASDAQ: PFWD)--

Who:    Phase Forward (NASDAQ: PFWD), a leading provider of data
        management solutions for clinical trials and drug safety

What:   Third Annual Phase Forward International Users Conference

When:   Tuesday, October 26 through Wednesday, October 27, 2004

Where:  Walt Disney Swan and Dolphin Hotel, Orlando, Florida

Phase Forward will hold its third annual International Users Conference on October 26-27 at the Walt Disney Swan and Dolphin Hotel in Orlando, Florida. This year's event will gather members of leading organizations from around the world - including Duke Clinical Research Institute, Eli Lilly and Company, Harvard Clinical Research Institute, Procter & Gamble Pharmaceuticals, Quintiles, Sanofi-Aventis, and Schering-Plough Research Institute - to discuss the clinical data management and safety challenges facing pharmaceutical, biotechnology, and medical device companies.

This year's event will feature:

--A keynote address on "Consumerism in Medicine: What does it mean for your company and its products?" presented by Dr. David Nash, Professor and Chairman, Department of Health Policy at Jefferson Medical College of Thomas Jefferson University. Dr. Nash will speak about the impact of consumerism in medicine and its implications for the future of health care, as well as examine ways companies can best anticipate and respond to this new dynamic.

--A customer keynote address, "Confronting Reality - Increasing Productivity in Drug Development," from G. Michael Wilson, Ph.D., Senior Director, Medical Information Sciences, Lilly Research Laboratories. Mr. Wilson will provide his perspective on important industry trends and hurdles, and share Lilly's clinical data management strategy.

--A panel discussion on lessons learned in electronic trials led by representatives from Schering-Plough Research Institute and Procter & Gamble Pharmaceuticals.

--Interactive sessions led by Phase Forward customers who will share their experiences on product implementation, migration and usage, trial and workflow design, and application integration.

--A presentation by Phase Forward's vice president of development on progress and plans for executing the Company's product roadmap.

Please visit Phase Forward's Web site to obtain more information regarding the event at www.phaseforward.com, or contact Phase Forward directly at 888-703-1122. For media inquiries, please contact Brian Gendron of SHIFT Communications at 617-681-1226.

About Phase Forward

Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. The company helps pharmaceutical, biotechnology, and medical device companies bring needed drugs and therapies to market faster and more safely. Phase Forward offers proven solutions in electronic data capture (EDC), clinical data management (CDM), and adverse event reporting (AER). Phase Forward products and services have been utilized in over 10,000 clinical trials involving more than 1,000,000 clinical trial study participants at over 200 organizations worldwide including: AstraZeneca, Biogen Idec, Boston Scientific, Cedars-Sinai, Eli Lilly and Company, GlaxoSmithKline, Guidant, Procter & Gamble, Quintiles, Sanofi-Aventis, and Schering-Plough Research Institute. Additional information about Phase Forward is available at www.phaseforward.com.